PLA2G4A and cancer: The sensitivity of several cancer cells, including renal, lung, liver, prostate, bladder, and mammary cancer cells to BV peptides such as melittin and phospholipase A2 together with the known permeability of these peptides through BBB allows to hope that BV may also be active against cancer located in the CNS (Oršolić, 2012).